Clarus Reports Fourth Quarter and Full Year 2025 Results

Rhea-AI Summary

Clarus (NASDAQ: CLAR) reported Q4 2025 sales of $65.4M, adjusted EBITDA of $1.2M and free cash flow of $11.6M. Full‑year 2025 sales were $250.4M with adjusted EBITDA of $1.1M. The company recorded non‑cash goodwill and intangible impairments of $29.9M in Q4 and expects 2026 sales of $255M–$265M and adjusted EBITDA of $9M–$11M. Liquidity improved with $36.7M cash and $0 total debt at year‑end.

Positive

• Free cash flow of $11.6M in Q4
• Adjusted net income of $3.6M in Q4
• Year‑end cash balance of $36.7M and $0 debt
• 2026 guidance: $255M–$265M sales and $9M–$11M adjusted EBITDA

Negative

• Adjusted EBITDA margin compressed from 6.1% to 1.8% in Q4
• Full‑year adjusted EBITDA margin fell to 0.4% from 2.6%
• Non‑cash impairment charges of $29.9M in Q4

News Market Reaction – CLAR

-3.55%

3 alerts

-3.55% News Effect

-$4M Valuation Impact

$113M Market Cap

0.1x Rel. Volume

On the day this news was published, CLAR declined 3.55%, reflecting a moderate negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $113M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q4 2025 Sales: $65.4M FY 2025 Sales: $250.4M Q4 Net Loss: $31.3M +5 more

8 metrics

Q4 2025 Sales $65.4M Fourth quarter 2025 sales vs $71.4M year-ago

FY 2025 Sales $250.4M Full year 2025 sales vs $264.3M in 2024

Q4 Net Loss $31.3M Fourth quarter 2025 net loss from continuing operations

FY Net Loss $46.6M Full year 2025 net loss from continuing operations

Q4 Adjusted EBITDA $1.2M (1.8% margin) Fourth quarter 2025 adjusted EBITDA vs $4.4M (6.1%) prior year

FY Adjusted EBITDA $1.1M (0.4% margin) Full year 2025 vs $6.9M (2.6%) in 2024

Cash Balance $36.7M Cash and cash equivalents at December 31, 2025

Total Debt $0.0M Total debt at December 31, 2025 vs $1.9M in 2024

Market Reality Check

Price: $2.99 Vol: Volume 159,524 versus 20-...

low vol

$2.99 Last Close

Volume Volume 159,524 versus 20-day average 255,401 indicates quieter-than-usual trading ahead of results. low

Technical Price $3.17 is trading below the 200-day MA at $3.49 and 29.6% under the 52-week high.

Peers on Argus

CLAR gained 1.93% with mixed peer moves: ESCA +1.03%, DOGZ +5.41%, AOUT +0.9%, J...

1 Up

CLAR gained 1.93% with mixed peer moves: ESCA +1.03%, DOGZ +5.41%, AOUT +0.9%, JAKK -0.19%, SRM +32.05%. Momentum scanner only flagged YYAI, suggesting stock-specific factors.

Previous Earnings Reports

5 past events · Latest: Nov 06 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 06	Quarterly earnings	Positive	+12.9%	Q3 2025 sales growth, higher margin, positive adjusted income from operations.
Jul 31	Quarterly earnings	Negative	-12.2%	Q2 2025 sales and gross margin declines with continued net loss.
May 08	Quarterly earnings	Negative	-7.9%	Q1 2025 revenue drop, swing to loss, guidance withdrawal and segment weakness.
Mar 06	Annual results	Positive	+4.0%	Q4/FY 2024 results with improved gross margin, debt reduction, and guidance.
Nov 07	Quarterly earnings	Negative	-7.2%	Q3 2024 sales decline, net loss, and reduced full‑year outlook.

Pattern Detected

Recent earnings releases often led to sizable moves, with an average same‑tag reaction of -2.07% and all five past events showing price moves aligned with the news tone.

Recent Company History

Over the past five earnings cycles from Nov 2024 through Nov 2025, Clarus reported declining year‑over‑year sales but worked on margin, portfolio, and balance sheet improvements. Q2 and Q1 2025 showed revenue pressure and losses, while Q3 2025 delivered modest growth and positive adjusted income. The 2024 annual results highlighted debt reduction and product simplification. Today’s Q4/FY 2025 release extends themes of restructuring, Adventure segment weakness, and improving adjusted profitability.

Historical Comparison

-2.1% avg move · In the past five earnings releases, CLAR’s average 24‑hour move was -2.07%. Today’s pre‑news gain of...

earnings

-2.1%

Average Historical Move earnings

In the past five earnings releases, CLAR’s average 24‑hour move was -2.07%. Today’s pre‑news gain of 1.93% sat modestly above that trend, suggesting less pessimism into this report.

Earnings from 2024–2025 show ongoing revenue pressure and losses, but improving adjusted income, portfolio simplification, and leverage reduction across Outdoor and Adventure segments.

Market Pulse Summary

This announcement details Q4 and full-year 2025 results showing lower sales of $65.4M for the quarte...

Analysis

This announcement details Q4 and full-year 2025 results showing lower sales of $65.4M for the quarter and $250.4M for the year, continued net losses, and much slimmer adjusted EBITDA of $1.1M for 2025. Management emphasizes simplification, Adventure segment challenges, and a debt-free balance sheet. Historically, Clarus’ earnings have produced volatile moves, so investors may watch execution against 2026 guidance and segment mix shifts closely.

Key Terms

adjusted ebita, free cash flow, pfas, net operating loss carryforwards, +3 more

7 terms

adjusted ebita financial

"Fourth Quarter Sales of $65.4 million, Adjusted EBITDA of $1.2 million..."

Adjusted EBITA is a measure of a company’s operating profit before interest, taxes and amortization, further modified to remove one-time or unusual items so it reflects ongoing business earnings. It matters to investors because it aims to show the company’s core cash-making ability — like listening to an engine without road noise — making comparisons across periods or peers easier, though companies may differ in what they exclude.

free cash flow financial

"Adjusted EBITDA of $1.2 million, and Free Cash Flow of $11.6 million..."

Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.

pfas medical

"offset by a favorable product mix and lower PFAS inventory reserves..."

PFAS are a group of human-made chemicals used in many everyday products, such as non-stick cookware, water-repellent clothing, and food packaging, because they resist heat, water, and grease. They are often called "forever chemicals" because they do not break down easily in the environment or the human body, potentially leading to health concerns. For investors, the presence of PFAS-related risks can impact companies’ reputations, legal liabilities, and future costs.

net operating loss carryforwards financial

"the Company had net operating loss carryforwards (“NOLs”) and research..."

Net operating loss carryforwards are tax rules that let a company apply past operating losses against future taxable profits, reducing the amount of tax it must pay when it returns to profitability. Think of it like a negative balance in a tax ledger that can be used to lower future tax bills, improving after-tax cash flow and earnings; investors track the size, expiration rules and any limits because they affect valuation and future cash available to the business.

deferred tax assets financial

"valuation allowance associated with deferred tax assets for the full year..."

An item on a company’s balance sheet showing tax benefits it can use later to reduce future tax bills — think of it as an IOU from the tax system for past losses or timing differences. It matters to investors because it can boost future cash flow and apparent value if the company expects profits ahead, but those benefits vanish if the company cannot generate taxable income and the asset must be reduced.

indefinite-lived intangible assets financial

"impairment of goodwill and indefinite-lived intangible assets for the fourth quarter..."

Indefinite-lived intangible assets are non-physical items such as brand names, trademarks, or perpetual rights that a company expects to keep indefinitely and therefore does not amortize over time. They matter to investors because their value stays on the balance sheet until shown to be impaired, so sudden write-downs can sharply reduce reported earnings and book value; think of them like a family recipe that retains value until someone proves it no longer sells.

original equipment manufacturer technical

"due to significantly lower demand from global original equipment manufacturer customers..."

An original equipment manufacturer (OEM) is a company that designs and builds parts or complete products that other firms sell under their own brand name, like a bakery making cakes that coffee shops rebrand and sell. Investors care because OEMs often win steady, long-term contracts, predictable production volumes and thin but scalable profit margins, so changes in their order book or supply chain can signal future revenue and risk for both the OEM and the brands that rely on it.

AI-generated analysis. Not financial advice.

Fourth Quarter Sales of $65.4 million, Adjusted EBITDA of $1.2 million, and Free Cash Flow of $11.6 million

Continued Focus on Simplification Strategy to Position Company for Profitable Growth

Apparel Sales in the Outdoor segment up 10% in the Fourth Quarter

SALT LAKE CITY, March 05, 2026 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the fourth quarter and full year ended December 31, 2025.

Fourth Quarter 2025 Financial Summary vs. Same Year‐Ago Quarter

• Sales of $65.4 million compared to $71.4 million.
• Gross margin was 27.7% compared to 33.4%; adjusted gross margin of 33.6% compared to 38.0%.
• Net loss of $31.3 million, or $(0.81) per diluted share¹, compared to net loss(including the impact of discontinued operations) of $65.5 million, or $(1.71) per diluted share².
• Loss from continuing operations of $31.3 million, or $(0.81) per diluted share, compared to loss from continuing operations of $73.3 million, or $(1.92) per diluted share.
• Adjusted net income of $3.6 million, or $0.09 per diluted share, compared to adjusted net loss of $3.2 million, or $(0.08) per diluted share.
• Adjusted EBITDA of $1.2 million with an adjusted EBITDA margin of 1.8% compared to $4.4 million with an adjusted EBITDA margin of 6.1%.

2025 Financial Summary vs. 2024

• Sales of $250.4 million compared to $264.3 million.
• Gross margin was 33.1% compared to 35.0%; adjusted gross margin was 34.9% compared to 37.5%.
• Net loss of $46.6 million, or $(1.21) per diluted share¹, compared to net loss (including the impact of discontinued operations)of $52.3 million, or $(1.37) per diluted share³.
• Loss from continuing operations of $46.6 million, or $(1.21) per diluted share, compared to loss from continuing operations of $88.4 million, or $(2.31) per diluted share.
• Adjusted income from continuing operations of $3.7 million, or $0.10 per diluted share, compared to adjusted loss from continuing operations of $2.6 million, or $(0.07) per diluted share.
• Adjusted EBITDA of $1.1 million with an adjusted EBITDA margin of 0.4% compared to $6.9 million with an adjusted EBITDA margin of 2.6%.

¹ Includes $29.9 million and $31.4 million impairment of goodwill and indefinite-lived intangible assets for the fourth quarter and full year ended December 31, 2025, respectively.

² Includes $44.8 million impairment of goodwill and indefinite-lived intangible assets as well as a $21.0 million tax expense for the establishment of a valuation allowance associated with deferred tax assets for the fourth quarter ended December 31, 2024.

³ Includes a gain on the sale of the Precision Sport segment of $40.6 million as well as $44.8 million impairment of goodwill and indefinite-lived intangible assets as well as a $21.0 million tax expense for the establishment of a valuation allowance associated with deferred tax assets for the full year ended December 31, 2024.

Management Commentary
“We took decisive actions in 2025 to sharpen our focus and position Clarus for category-specific growth and greater profitability,” said Warren Kanders, Executive Chairman. “We advanced our strategic roadmap throughout the year by refining our organizational structure, optimizing our product portfolio, and strengthening our go-to-market approach.   In the Outdoor segment, we achieved consecutive quarters of improved performance driven by prioritizing Black Diamond’s highest-performing and most profitable styles, positioning the business for sustained profitability and operating margin expansion. Apparel continued to be a key growth driver, delivering another quarter of double-digit sales growth in Q4.   In the Adventure segment, despite experiencing lower OEM demand and customer transitions, we took steps to enhance our leadership position in Australia. We saw new customer wins and sell-in in Australia and Europe, which we believe will lay the groundwork for improved performance going forward.”

Mr. Kanders added, “As we look to 2026, we expect ongoing volatility in the global consumer environment, but the Company is significantly better positioned than this time last year. Following a multi-year transformation, the Black Diamond organization is leaner, more focused, and more competitive, and we expect our strategic initiatives to drive improved profitability. At Adventure, we are balancing growth and operational execution while advancing a robust pipeline of innovative products, with multiple new platforms expected to launch over the next 18 months. With a debt-free balance sheet and strong liquidity, we remain focused on executing our long-term growth strategy, disciplined capital allocation, and maximizing shareholder value.”

Fourth Quarter 2025 Financial Results
Sales in the fourth quarter were $65.4 million compared to $71.4 million in the same year‐ago quarter. Sales in the Outdoor segment decreased 8% to $47.2 million, compared to $51.1 million in the same year-ago quarter. Sales in the Adventure segment decreased 10% to $18.2 million, compared to $20.3 million in the year-ago quarter.

The decrease in Outdoor sales was due to softness in North America wholesale, lower global DTC revenues, and lower PIEPS revenue due to its sale in July 2025, partially offset by an increase in IGD and Europe wholesale revenue.   IGD and Europe wholesale sales in the Outdoor segment were up $1.4 million, or 9%. Apparel globally was up 10% in the fourth quarter.

The decrease in sales in the Adventure segment reflects significantly reduced demand from global OEM customers and a challenging wholesale market in Australia for Rhino-Rack, partially offset by increased contributions from the acquisition of RockyMounts. RockyMounts contributed $1.0 million in incremental sales growth compared to the prior year period.
        
Gross margin in the fourth quarter was 27.7% compared to 33.4% in the year‐ago quarter. The decrease in gross margin was primarily due to higher inventory reserves within the Adventure segment to address slow-moving and obsolete inventory, tariff impacts at both segments, lower volumes at the Outdoor segment due to the sale of PIEPS, and unfavorable foreign currency impacts at the Outdoor segment. These decreases were partially offset by a favorable product mix and lower PFAS inventory reserves at the Outdoor segment. Adjusted gross margin, reflecting the PFAS related and other inventory reserves and inventory fair value adjustments as a result of purchase accounting, was 33.6% for the quarter compared to 38.0% in the year-ago quarter.

Selling, general and administrative expenses in the fourth quarter were $25.5 million compared to $27.8 million in the same year‐ago quarter. The decrease was primarily due to lower employee-related expenses, lower costs from PIEPS due to its sale, as well as expense reduction initiatives across both segments and at Corporate to manage costs.

During the fourth quarter of 2025, the Company incurred non-cash impairment charges for goodwill and indefinite-lived assets of $29.9 million. During the fourth quarter of 2024, the Company incurred non-cash impairment charges for goodwill and indefinite-lived assets of $44.8 million as well as an increase in tax expense of $21.0 million for a valuation allowance to fully reserve all deferred tax assets associated with U.S. federal income taxes.

The loss from continuing operations in the fourth quarter of 2025 was $31.3 million, or $(0.81) per diluted share, compared to loss from continuing operations of $73.3 million, or $(1.92) per diluted share in the year-ago quarter. Loss from continuing operations in the fourth quarter included a non-cash impairment charge for goodwill and indefinite-lived intangible assets of $29.9 million in the Adventure segment due to the sustained decline in the Company’s stock price and lower sales and profitability in the segment compared to expectations. The loss also includes $9.3 million of costs and charges associated with amortization of intangibles, restructuring charges, transactions costs, disposal of internally developed software, PFAS and other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted net income in the fourth quarter of 2025 was $3.6 million, or $0.09 per diluted share, compared to adjusted net loss of $3.2 million, or $(0.08) per diluted share, in the year-ago quarter. Adjusted net loss excludes legal costs and regulatory matters expenses, restructuring charges and transaction costs, as well as non-cash items for intangible amortization, impairment of goodwill and indefinite-lived intangible assets, disposal of internally developed software, inventory fair value of purchase accounting, PFAS and other inventory reserves, deferred tax valuation allowance, and stock-based compensation.

Adjusted EBITDA in the fourth quarter was $1.2 million, or an adjusted EBITDA margin of 1.8%, compared to adjusted EBITDA of $4.4 million, or an adjusted EBITDA margin of 6.1%, in the same year‐ago quarter.

Net cash provided by operating activities for the three months ended December 31, 2025, was $12.5 million compared to net cash provided of $16.6 million in the prior year quarter. Capital expenditures in the fourth quarter of 2025 were $0.9 million compared to $2.2 million in the prior year quarter. Free cash flow for the fourth quarter of 2025 was $11.6 million.

Liquidity at December 31, 2025 vs. December 31, 2024

• Cash and cash equivalents totaled $36.7 million compared to $45.4 million.
• Total debt of $0.0 million compared to $1.9 million.

Full Year 2025 Financial Results
Sales in 2025 decreased 5.2% to $250.4 million compared to $264.3 million in 2024. The decrease in sales in the Adventure segment was due to significantly lower demand from global original equipment manufacturer customers and a challenging wholesale market in Australia for both Rhino-Rack and MAXTRAX, combined with a prior year large wholesale customer in North America not recurring in 2025, which was partially offset by the benefit from the RockyMounts acquisition. Sales in the Outdoor segment decreased due to lower independent global distributor revenue, lower global direct-to-consumer revenue and a decrease due to the sale of PIEPS in July 2025. Prior to its sale, PIEPS revenue was $2.1 million in 2025, compared to $5.5 million for the full year 2024.

From a segment perspective, Outdoor sales were down $6.7 million or 3.7% to $176.9 million and Adventure sales were down $7.2 million or 8.9% to $73.6 million.

Gross margin in 2025 was 33.1% compared to 35.0% in 2024 primarily due to lower volumes at the Outdoor and Adventure segments, impacts due to tariffs imposed by the United States for both segments, and an unfavorable product mix at the Adventure segment. This was partially offset by a favorable product mix at the Outdoor segment due to simplification initiatives.

Selling, general and administrative expenses in 2025 were $105.2 million compared to $111.9 million in 2024. The decrease was primarily due to lower digital marketing and employee-related costs, lower costs from PIEPS due to its sale in July 2025, as well as lower retail expenses due to store closures and other expense reduction initiatives to manage costs across the businesses and corporate.

Loss from continuing operations in 2025 was $46.6 million, or $(1.21) per diluted share, compared to net loss of $88.4 million, or $(2.31) per diluted share, in the prior year. Loss from continuing operations for 2025 included a non-cash impairment of goodwill and indefinite-lived intangible assets charge of $29.9 million in the Adventure segment and a $1.6 million impairment of indefinite-lived intangible assets in the Outdoor segment, specifically the PIEPS trademark. The loss also includes $25.7 million of cost and charges associated with amortization of intangibles, restructuring charges, transactions costs, contingent consideration benefits, disposal of internally developed software, other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted income from continuing operations in 2025 was $3.7 million, or $0.10 per diluted share, compared to adjusted loss from continuing operations in 2024 of $2.6 million, or $(0.07) per diluted share. Adjusted net loss excludes legal cost and regulatory matters expenses, restructuring charges and transaction costs, as well as non-cash items for intangible amortization, impairment of goodwill and indefinite-lived intangible assets, disposal of internally developed software, inventory fair value of purchase accounting, PFAS and other inventory reserves, contingent consideration benefits, deferred tax valuation allowance, and stock-based compensation.

Adjusted EBITDA in 2025 was $1.1 million, or an adjusted EBITDA margin of 0.4%, compared to $6.9 million, or an adjusted EBITDA margin of 2.6%, in 2024.

Net cash used in operating activities for the year ended December 31, 2025, was $4.7 million compared to net cash used in operating activities of $7.3 million in 2024. Capital expenditures in 2025 were $5.2 million compared to $6.7 million in the prior year. Free cash flow for the year ended December 31, 2025, was an outflow of $9.9 million compared to an outflow of $14.0 million in the same year‐ago period.

2026 Outlook
The Company expects fiscal year 2026 sales to range between $255 million and $265 million and adjusted EBITDA to range between approximately $9 million and $11 million, or an adjusted EBITDA margin of 3.8% at the mid-point of revenue and adjusted EBITDA. In addition, capital expenditures are expected to range between $6 million and $7 million and free cash flow is expected to range between $3 and $4 million for the full year 2026. Clarus has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA and/or Adjusted EBITDA Margin. Therefore, we do not provide a reconciliation of Adjusted EBITDA and/or Adjusted EBITDA Margin guidance to net income guidance for fiscal year 2026.

Net Operating Loss (NOL) and Deferred Tax Asset Valuation Allowance
As of December 31, 2025, the Company had net operating loss carryforwards (“NOLs”) and research and experimentation credit for U.S. federal income tax purposes of $41.2 million and $5.7 million, respectively. All federal NOLs will have an indefinite carryforward period. Federal research and experimentation credits have a limited carryforward period and will begin to expire in tax year 2033.

Conference Call
The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its fourth quarter 2025 results.

Date: Thursday, March 5, 2026
Time: 5:00 pm ET
Registration Link: https://register-conf.media-server.com/register/BI94bda81119fd427295496ddd3b0b57f4

To access the call by phone, please register via the live call registration link above and you will be provided with dial-in instructions and details. The conference call will be broadcast live and available for replay here and on the Company’s website at www.claruscorp.com.

About Clarus Corporation
Headquartered in Salt Lake City, Utah, Clarus Corporation is a global leader in the design and development of best-in-class equipment and lifestyle products for outdoor enthusiasts. Driven by our rich history of engineering and innovation, our objective is to provide safe, simple, effective and beautiful products so that our customers can maximize their outdoor pursuits and adventures. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond^®, Rhino-Rack^®, MAXTRAX^®, TRED Outdoors^®, and RockyMounts^® brand names through outdoor specialty and online retailers, our own websites, distributors, and original equipment manufacturers.

Use of Non‐GAAP Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). This press release contains the non-GAAP measures: (i) adjusted gross margin and adjusted gross profit, (ii) adjusted (loss) income from continuing operations and related earnings (loss) per diluted share, (iii) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), EBITDA margin, adjusted EBITDA, and adjusted EBITDA margin, and (iv) free cash flow (defined as net cash provided by operating activities less capital expenditures). The Company believes that the presentation of certain non-GAAP measures, i.e.: (i) adjusted gross margin and adjusted gross profit, (ii) adjusted (loss) income from continuing operations and related earnings (loss) per diluted share, (iii) EBITDA, EBITDA margin, adjusted EBITDA and adjusted EBITDA margin, and (iv) free cash flow, provide useful information for the understanding of its ongoing operations and enable investors to focus on period-over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measures adjusted EBITDA and/or adjusted EBITDA margin for the fiscal year 2026 to net income for the fiscal year 2026, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not adjusted EBITDA and/or adjusted EBITDA margin. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

Forward-Looking Statements
Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled “Risk Factors” in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company’s Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

Company Contact:
Michael J. Yates
Chief Financial Officer
mike.yates@claruscorp.com

Investor Relations:
The IGB Group
Leon Berman / Matt Berkowitz
Tel 1-212-477-8438 / 1-212-227-7098
lberman@igbir.com / mberkowitz@igbir.com

CLARUS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share amounts)
	December 31, 2025				December 31, 2024
Assets
Current assets
Cash	$	36,691			$	45,359
Accounts receivable, net		44,839				43,678
Inventories		83,028				82,278
Prepaid and other current assets		5,457				5,555
Income tax receivable		1,407				910
Total current assets		171,422				177,780
Property and equipment, net		18,255				17,606
Other intangible assets, net		23,761				31,516
Indefinite-lived intangible assets		19,600				46,750
Goodwill		-				3,804
Deferred income taxes		55				36
Other long-term assets		15,935				16,602
Total assets	$	249,028			$	294,094
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	15,907			$	11,873
Accrued liabilities		24,403				22,276
Income tax payable		179				-
Current portion of long-term debt		-				1,888
Total current liabilities		40,489				36,037
Deferred income taxes		1,418				12,210
Other long-term liabilities		10,728				12,754
Total liabilities		52,635				61,001
Stockholders’ Equity
Preferred stock, $0.0001 par value per share; 5,000 shares authorized; none issued		-				-
Common stock, $0.0001 par value per share; 100,000 shares authorized; 43,054 and 43,004 issued and 38,402 and 38,362 outstanding, respectively		4				4
Additional paid in capital		703,487				697,592
Accumulated deficit		(457,253	)			(406,857	)
Treasury stock, at cost		(33,156	)			(33,114	)
Accumulated other comprehensive loss		(16,689	)			(24,532	)
Total stockholders’ equity		196,393				233,093
Total liabilities and stockholders’ equity	$	249,028			$	294,094

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
(Unaudited)
(In thousands, except per share amounts)
	Three Months Ended
	December 31, 2025				December 31, 2024
Sales
Domestic sales	$	28,329			$	30,162
International sales		37,084				41,243
Total sales		65,413				71,405
Cost of goods sold		47,277				47,540
Gross profit		18,136				23,865
Operating expenses
Selling, general and administrative		25,492				27,772
Restructuring charges		478				939
Transaction costs		66				408
Legal costs and regulatory matter expenses		1,219				47
Impairment of goodwill		3,804				36,264
Impairment of indefinite-lived intangible assets		26,069				8,545
Total operating expenses		57,128				73,975
Operating loss		(38,992	)			(50,110	)
Other income (expense)
Interest income, net		101				269
Other, net		974				(2,342	)
Total other income (expense), net		1,075				(2,073	)
Loss before income tax		(37,917	)			(52,183	)
Income tax (benefit) expense		(6,656	)			21,142
Loss from continuing operations		(31,261	)			(73,325	)
Discontinued operations, net of tax		-				7,804
Net loss	$	(31,261	)		$	(65,521	)
Loss from continuing operations per share:
Basic	$	(0.81	)		$	(1.92	)
Diluted		(0.81	)			(1.92	)
Net loss per share:
Basic	$	(0.81	)		$	(1.71	)
Diluted		(0.81	)			(1.71	)
Weighted average shares outstanding:
Basic		38,402				38,262
Diluted		38,402				38,262

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
(Unaudited)
(In thousands, except per share amounts)
	Twelve Months Ended
	December 31, 2025				December 31, 2024
Sales
Domestic sales	$	106,123			$	105,745
International sales		144,317				158,570
Total sales		250,440				264,315
Cost of goods sold		167,464				171,696
Gross profit		82,976				92,619
Operating expenses
Selling, general and administrative		105,173				111,948
Restructuring charges		967				1,948
Transaction costs		752				576
Contingent consideration benefit		(355	)			(125	)
Legal costs and regulatory matter expenses		4,682				3,842
Impairment of goodwill		3,804				36,264
Impairment of indefinite-lived intangible assets		27,634				8,545
Total operating expenses		142,657				162,998
Operating loss		(59,681	)			(70,379	)
Other income (expense)
Interest income, net		619				1,467
Other, net		1,973				(1,673	)
Total other income (expense), net		2,592				(206	)
Loss before income tax		(57,089	)			(70,585	)
Income tax (benefit) expense		(10,533	)			17,852
Loss from continuing operations		(46,556	)			(88,437	)
Discontinued operations, net of tax		-				36,150
Net loss	$	(46,556	)		$	(52,287	)
Loss from continuing operations per share:
Basic	$	(1.21	)		$	(2.31	)
Diluted		(1.21	)			(2.31	)
Net loss per share:
Basic	$	(1.21	)		$	(1.37	)
Diluted		(1.21	)			(1.37	)
Weighted average shares outstanding:
Basic		38,393				38,305
Diluted		38,393				38,305

CLARUS CORPORATION
RECONCILIATION FROM GROSS PROFIT TO ADJUSTED GROSS PROFIT
AND ADJUSTED GROSS MARGIN
THREE MONTHS ENDED
		December 31, 2025						December 31, 2024
Sales		$	65,413			Sales		$	71,405
Gross profit as reported		$	18,136			Gross profit as reported		$	23,865
Plus impact of inventory fair value adjustment			-			Plus impact of inventory fair value adjustment			61
Plus impact of other inventory reserves			3,840			Plus impact of PFAS and other inventory reserves			3,179
Adjusted gross profit		$	21,976			Adjusted gross profit		$	27,105
Gross margin as reported			27.7	%		Gross margin as reported			33.4	%
Adjusted gross margin			33.6	%		Adjusted gross margin			38.0	%
TWELVE MONTHS ENDED
		December 31, 2025						December 31, 2024
Sales		$	250,440			Sales		$	264,315
Gross profit as reported		$	82,976			Gross profit as reported		$	92,619
Plus impact of inventory fair value adjustment			120			Plus impact of inventory fair value adjustment			61
Plus impact of other inventory reserves			4,330			Plus impact of PFAS and other inventory reserves			6,502
Adjusted gross profit		$	87,426			Adjusted gross profit		$	99,182
Gross margin as reported			33.1	%		Gross margin as reported			35.0	%
Adjusted gross margin			34.9	%		Adjusted gross margin			37.5	%

CLARUS CORPORATION
RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED INCOME (LOSS) FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE
(In thousands, except per share amounts)
	Three Months Ended December 31, 2025
	Total			Gross			Operating				Income tax				Tax				(Loss) income from				Diluted
	sales			profit			expenses				(benefit) expense				rate				continuing operations				EPS(1)
As reported	$	65,413		$	18,136		$	57,128			$	(6,656	)		(17.6	)	%		$	(31,261	)		$	(0.81	)
Amortization of intangibles		-			-			(2,154	)			122								2,032
Impairment of goodwill		-			-			(3,804	)			576								3,228
Impairment of indefinite-lived intangible assets		-			-			(26,069	)			8,181								17,888
Disposal of internally developed software		-			-			(222	)			-								222
Restructuring charges		-			-			(478	)			55								423
Transaction costs		-			-			(66	)			163								(97	)
Other inventory reserves		-			3,840			-				1,072								2,768
Legal costs and regulatory matter expenses		-			-			(1,219	)			986								233
Stock-based compensation		-			-			(1,327	)			392								935
Valuation allowance		-			-			-				(7,292	)							7,292
As adjusted	$	65,413		$	21,976		$	21,789			$	(2,376	)		(188.3	)	%		$	3,638			$	0.09
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 38,402 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,452 diluted shares of common stock.
	Three Months Ended December 31, 2024
	Total			Gross			Operating				Income tax				Tax				(Loss) income from				Diluted
	sales			profit			expenses				(benefit) expense				rate				continuing operations				EPS(1)
As reported	$	71,405		$	23,865		$	73,975			$	21,142			40.5		%		$	(73,325	)		$	(1.92	)
Amortization of intangibles		-			-			(2,468	)			1,240								1,228
Impairment of goodwill		-			-			(36,264	)			-								36,264
Impairment of indefinite-lived intangible assets		-			-			(8,545	)			2,564								5,981
Restructuring charges		-			-			(939	)			251								688
Transaction costs		-			-			(408	)			87								321
Inventory fair value of purchase accounting		-			61			-				13								48
PFAS and other inventory reserves		-			3,179			-				766								2,413
Legal costs and regulatory matter expenses		-			-			(47	)			23								24
Stock-based compensation		-			-			(1,570	)			(588	)							2,158
Valuation allowance		-			-			-				(21,038	)							21,038
As adjusted	$	71,405		$	27,105		$	23,734			$	4,460			343.6		%		$	(3,162	)		$	(0.08	)
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,262 basic and diluted weighted average shares of common stock.

CLARUS CORPORATION
RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED INCOME (LOSS) FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE
(In thousands, except per share amounts)
	Twelve Months Ended December 31, 2025
	Total			Gross			Operating				Income tax				Tax				(Loss) income from				Diluted
	sales			profit			expenses				(benefit) expense				rate				continuing operations				EPS(1)
As reported	$	250,440		$	82,976		$	142,657			$	(10,533	)		(18.5	)	%		$	(46,556	)		$	(1.21	)
Amortization of intangibles		-			-			(8,740	)			2,385								6,355
Impairment of goodwill		-			-			(3,804	)			576								3,228
Impairment of indefinite-lived intangible assets		-			-			(27,634	)			8,181								19,453
Disposal of internally developed software		-			-			(587	)			177								410
Restructuring charges		-			-			(967	)			241								726
Transaction costs		-			-			(752	)			162								590
Contingent consideration benefit		-			-			355				-								(355	)
Inventory fair value of purchase accounting		-			120			-				25								95
Other inventory reserves		-			4,330			-				1,072								3,258
Legal costs and regulatory matter expenses		-			-			(4,682	)			983								3,699
Stock-based compensation		-			-			(5,895	)			391								5,504
Valuation allowance		-			-			-				(7,292	)							7,292
As adjusted	$	250,440		$	87,426		$	89,951			$	(3,632	)		(5,420.9	)	%		$	3,699			$	0.10
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 38,393 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,443 diluted shares of common stock.
	Twelve Months Ended December 31, 2024
	Total			Gross			Operating				Income tax				Tax				(Loss) income from				Diluted
	sales			profit			expenses				(benefit) expense				rate				continuing operations				EPS(1)
As reported	$	264,315		$	92,619		$	162,998			$	17,852			25.3		%		$	(88,437	)		$	(2.31	)
Amortization of intangibles		-			-			(9,784	)			2,751								7,033
Impairment of goodwill		-			-			(36,264	)			-								36,264
Impairment of indefinite-lived intangible assets		-			-			(8,545	)			2,564								5,981
Restructuring charges		-			-			(1,948	)			459								1,489
Transaction costs		-			-			(576	)			122								454
Contingent consideration benefit		-			-			125				(26	)							(99	)
Inventory fair value of purchase accounting		-			61			-				13								48
PFAS and other inventory reserves		-			6,502			-				1,453								5,049
Legal costs and regulatory matter expenses		-			-			(3,842	)			807								3,035
Stock-based compensation		-			-			(5,823	)			291								5,532
Valuation allowance		-			-			-				(21,038	)							21,038
As adjusted	$	264,315		$	99,182		$	96,341			$	5,248			199.2		%		$	(2,613	)		$	(0.07	)
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,305 basic and diluted weighted average shares of common stock.

CLARUS CORPORATION
RECONCILIATION FROM OPERATING INCOME (LOSS) TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN
(In thousands)
	Three Months Ended December 31, 2025																	Three Months Ended December 31, 2024
	Outdoor Segment				Adventure Segment				Corporate Costs				Total					Outdoor Segment				Adventure Segment				Corporate Costs				Total
Operating income (loss)	$	(553	)		$	(35,485	)		$	(2,954	)		$	(38,992	)			$	1,897			$	(48,582	)		$	(3,425	)		$	(50,110	)
Depreciation		587				400				-				987					614				369				-				983
Amortization of intangibles		223				1,931				-				2,154					285				2,183				-				2,468
EBITDA		257				(33,154	)			(2,954	)			(35,851	)				2,796				(46,030	)			(3,425	)			(46,659	)
Restructuring charges		467				11				-				478					789				150				-				939
Transaction costs		44				-				22				66					65				307				36				408
Legal costs and regulatory matter expenses		775				-				444				1,219					10				-				37				47
Impairment of goodwill		-				3,804				-				3,804					-				36,264				-				36,264
Impairment of indefinite-lived intangible assets		-				26,069				-				26,069					-				8,545				-				8,545
Disposal of internally developed software		-				222				-				222					-				-				-				-
Stock-based compensation		-				-				1,327				1,327					-				-				1,570				1,570
Inventory fair value of purchase accounting		-				-				-				-					-				61				-				61
PFAS and other inventory reserves		459				3,381				-				3,840					869				2,310				-				3,179
Adjusted EBITDA	$	2,002			$	333			$	(1,161	)		$	1,174				$	4,529			$	1,607			$	(1,782	)		$	4,354
Sales	$	47,191			$	18,222			$	-			$	65,413				$	51,072			$	20,333			$	-			$	71,405
EBITDA margin		0.5		%		(181.9	)	%						(54.8	)	%			5.5		%		(226.4	)	%						(65.3	)	%
Adjusted EBITDA margin		4.2		%		1.8		%						1.8		%			8.9		%		7.9		%						6.1		%

CLARUS CORPORATION
RECONCILIATION FROM OPERATING LOSS TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN
(In thousands)
	Twelve Months Ended December 31, 2025																	Twelve Months Ended December 31, 2024
	Outdoor Segment				Adventure Segment				Corporate Costs				Total					Outdoor Segment				Adventure Segment				Corporate Costs				Total
Operating loss	$	(1,452	)		$	(42,463	)		$	(15,766	)		$	(59,681	)			$	(999	)		$	(53,126	)		$	(16,254	)		$	(70,379	)
Depreciation		2,177				1,464				-				3,641					2,588				1,446				-				4,034
Amortization of intangibles		973				7,767				-				8,740					1,142				8,642				-				9,784
EBITDA		1,698				(33,232	)			(15,766	)			(47,300	)				2,731				(43,038	)			(16,254	)			(56,561	)
Restructuring charges		599				368				-				967					1,349				599				-				1,948
Transaction costs		614				40				98				752					65				396				115				576
Contingent consideration benefit		-				(355	)			-				(355	)				-				(125	)			-				(125	)
Legal costs and regulatory matter expenses		2,825				-				1,857				4,682					3,088				-				754				3,842
Impairment of goodwill		-				3,804				-				3,804					-				36,264				-				36,264
Impairment of indefinite-lived intangible assets		1,565				26,069				-				27,634					-				8,545				-				8,545
Disposal of internally developed software		-				587				-				587					-				-				-				-
Stock-based compensation		-				-				5,895				5,895					-				-				5,823				5,823
Inventory fair value of purchase accounting		-				120				-				120					-				61				-				61
PFAS and other inventory reserves		949				3,381				-				4,330					4,192				2,310				-				6,502
Adjusted EBITDA	$	8,250			$	782			$	(7,916	)		$	1,116				$	11,425			$	5,012			$	(9,562	)		$	6,875
Sales	$	176,863			$	73,577			$	-			$	250,440				$	183,568			$	80,747			$	-			$	264,315
EBITDA margin		1.0		%		(45.2	)	%						(18.9	)	%			1.5		%		(53.3	)	%						(21.4	)	%
Adjusted EBITDA margin		4.7		%		1.1		%						0.4		%			6.2		%		6.2		%						2.6		%

FAQ

What were Clarus (CLAR) fourth quarter 2025 sales and adjusted EBITDA?

Clarus reported $65.4M in Q4 2025 sales and $1.2M adjusted EBITDA. According to Clarus, adjusted EBITDA margin was 1.8%, down from 6.1% year‑over‑year due to mix, reserves, and lower volumes.

How did Clarus (CLAR) perform on free cash flow and liquidity in Q4 2025?

Clarus generated $11.6M free cash flow in Q4 2025 and ended year with $36.7M cash. According to Clarus, total debt was $0, reflecting a debt‑free balance sheet and stronger liquidity.

What impairment charges did Clarus (CLAR) record in Q4 2025 and why?

Clarus recorded a $29.9M non‑cash goodwill and intangible impairment in Q4 2025. According to Clarus, the charge related to lower sales and profitability in the Adventure segment and a sustained decline in stock price.

What is Clarus (CLAR) fiscal year 2026 guidance for sales and adjusted EBITDA?

Clarus expects 2026 sales of $255M–$265M and adjusted EBITDA of $9M–$11M. According to Clarus, this implies an approximate mid‑point adjusted EBITDA margin near 3.8% and planned $6M–$7M capex.